An Educational Partnership with the University of Florida College of Pharmacy Hardly a workday goes by that medical publication professionals aren’t faced with the business challenge to communicate the value of a drug to new stakeholders. This rapidly evolving...
Author responsiveness concerns in the wake of the coronavirus disease (COVID-19) global pandemic has resulted in apprehension and numerous inquiries from ISMPP members over the past several weeks. To address these unprecedented circumstances, ISMPP convened a...
Katherine Baria, BSc (ARCS), PhD, AstraZeneca, Gaithersburg, MD, USA; Richard Baker, ISMPP CMPP™, BSc (Hons), Novartis, Basel, Switzerland; Claire Bartlett, ISMPP CMPP™, BA (Hons), CMC Connect, McCann Health Medical Communications, Macclesfield, UK; Belinda Dean,...
The American Medical Writers Association (AMWA), European Medical Writers Association (EMWA), and International Society for Medical Publication Professionals (ISMPP) released their Joint Position Statement on Predatory Publishing in July 2019, published in Current...
Laurie Myers, MBA, Merck & Co., Inc. Communicating with patients about clinical trials is challenging in today’s increasingly complex world of treatment options. While access to information about clinical trials is more widely available, patients with serious...
